Sannova Analytical is a boutique Contract Research Organization dedicated to providing bioanalytical and analytical CMC services from early characterization to commercialization. With a strong emphasis on Quality, Speed and Flexibility, the company delivers fast, personalized, and end-to-end services for diverse therapeutic products, including complex, novel, and generic treatments. Since its establishment in 2006, Sannova Analytical has built a reputation for on-time project delivery, leveraging a state-of-the-art 21,000 square feet lab equipped with cutting-edge instrumentation.
Embracing the Health Care and Pharmaceutical industries, the company recently secured a Private Equity Round investment on 10 August 2022, with participation from SFW Capital Partners, Geeta Vidiyala, Malleswar Kollu, and Venkat Reddy. This investment signifies a pivotal moment for Sannova Analytical, reflecting confidence from prominent investors in the company's vision and potential for growth within the industry.
No recent news or press coverage available for Sannova Analytical.